BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22234527)

  • 1. Prevalence of monoclonal gammopathy of undetermined significance in Thailand.
    Watanaboonyongcharoen P; Nakorn TN; Rojnuckarin P; Lawasut P; Intragumtornchai T
    Int J Hematol; 2012 Feb; 95(2):176-81. PubMed ID: 22234527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.
    Dispenzieri A; Katzmann JA; Kyle RA; Larson DR; Melton LJ; Colby CL; Therneau TM; Clark R; Kumar SK; Bradwell A; Fonseca R; Jelinek DF; Rajkumar SV
    Lancet; 2010 May; 375(9727):1721-8. PubMed ID: 20472173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Immunotyping Distribution of Serum Monoclonal Paraprotein and Environmental Impact on Multiple Myeloma (MM) and Monoclonal Gammopathy of Uncertain Significance (MGUS) in Taiwan: A Medical Center-Based Experience.
    Chang CC; Su MJ; Lee SJ; Tsai YH; Kuo LY; Lin IH; Huang HL; Yen TH; Chu FY
    Asian Pac J Cancer Prev; 2016; 17(1):395-9. PubMed ID: 26838245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MGUS prevalence in an ethnically Chinese population in Hong Kong.
    Wu SP; Minter A; Costello R; Zingone A; Lee CK; Au WY; Landgren O
    Blood; 2013 Mar; 121(12):2363-4. PubMed ID: 23520330
    [No Abstract]   [Full Text] [Related]  

  • 7. [Monoclonal gammopathy of undetermined significance].
    Chaïbi P; Merlin L; Thomas C; Piette F
    Ann Med Interne (Paris); 2002 Nov; 153(7):459-66. PubMed ID: 12598832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L; Guffanti A; Cesana BM; Colombi M; Chiorboli O; Damilano I; Maiolo AT
    Blood; 1996 Feb; 87(3):912-8. PubMed ID: 8562962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for M-proteinemia consisting of monoclonal gammopathy of undetermined significance and multiple myeloma for 30 years among atomic bomb survivors in Hiroshima.
    Fujimura K; Sugiyama A; Akita T; Ohisa M; Nagashima S; Katayama K; Maeda R; Tanaka J
    Int J Hematol; 2021 Apr; 113(4):576-585. PubMed ID: 33389658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
    Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
    Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
    El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
    Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the prevalence and genetic predisposition of monoclonal gammopathy of undetermined significance (MGUS).
    Ruiz-Argüelles GJ; Ruiz-Delgado GJ
    Int J Hematol; 2012 Jul; 96(1):144-5. PubMed ID: 22661012
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoclonal gammopathy in a tertiary referral hospital.
    Tamimi W; Alaskar A; Alassiri M; Alsaeed W; Alarifi SA; Alenzi FQ; Jawdat D
    Clin Biochem; 2010 Jun; 43(9):709-13. PubMed ID: 20206156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China.
    Xu A; Guo T; Zhang S; Luo H; Shen M; Ye Y; Ji L
    Hematology; 2024 Dec; 29(1):2352686. PubMed ID: 38819332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
    Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
    N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A 71-year-old woman with multiple myeloma status after stem cell transplantation.
    Donato LJ; Zeldenrust SR; Murray DL; Katzmann JA
    Clin Chem; 2011 Dec; 57(12):1645-8. PubMed ID: 22125317
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal gammopathy of undetermined significance (MGUS) in patients with solid tumors: effects of chemotherapy on the monoclonal protein.
    Anagnostopoulos A; Galani E; Gika D; Sotou D; Evangelopoulou A; Dimopoulos MA
    Ann Hematol; 2004 Oct; 83(10):658-60. PubMed ID: 15278296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active multiple myeloma suppresses and typically eliminates coexisting MGUS.
    Campbell JP; Heaney JLJ; Pandya S; Afzal Z; Kaiser M; Owen R; Child JA; Gregory W; Morgan GJ; Jackson GH; Bunce CM; Drayson MT
    Br J Cancer; 2017 Sep; 117(6):835-839. PubMed ID: 28728165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.